CTRI/2018/03/012710尚未招募2 期
A Prospective Open Labelled Non Randomized Clinical Trial on herbal formulation of NERUNJI VER KUDINEER for the treatment of KALLADAIPPU[Urolithiasis]
Dr S Neelavathi MD PhD0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age from 30 years to 60 years Patient With Renal Colicky pain Nausea Vomiting
- •Haematuria Oliguria Pyuria Dysuria
排除标准
- •Age Below 30 years and above 60 years Chronic Appendicitis Cholecystitis Pyelonephritis Recurrent UTI Diabetes Mellitus Metabolic disorders like Hyperthyroidism Hyperparathyroidism
- •Pelvic Inflammatory Disease Chronic Renal Failure
研究者
相似试验
招募中
2 期
A clinical study to study the drug Seenthil Sarkkarai on NeerizhivuCTRI/2018/01/011497Dr S Neelavathi
已完成
不适用
Cosmetic formulation of a fairness cream in Female and Male subjects to check the fairness effectCTRI/2019/04/018629eeford Healthcare Limited India60
尚未招募
4 期
To evaluate the safety and efficacy of Endotone polyherbal capsule in treatment of Endometriosis.CTRI/2022/10/046666Charak Pharma Pvt Ltd
进行中（未招募）
1 期
A prospective, open label, non-randomised, clinical trial to determine if natalizumab (Tysabri) improves ambulatory measures in relapsing remitting multiple sclerosis (RRMS) patients. - TIMERMultiple sclerosisMedDRA version: 9.1Level: LLTClassification code 10063399Term: Relapsing-remitting multiple sclerosisEUCTR2009-009503-19-BEBiogen Idec International GmbH200
招募中
2 期
A clinical trail to study the effect of drug LAVANKATHI CHOORANAM on Iya iraippu noi Bronchial AsthmaCTRI/2018/04/013233Prof Dr S Neelavathi